
|Articles|May 9, 2008
Bevacizumab improves success rate of augmented trabeculectomy for neovascular glaucoma in young diabetic patients
The addition of bevacizumab (Avastin) to trabeculectomy improves the success rate of IOP control, particularly in young diabetic patients with neovascular glaucoma (NVG), according to a study published online, ahead of print, by Eye.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
When heat misses the mark: Why warm compresses don’t always work
2
Similarity in corneal biomechanics between 2 major glaucoma types: More alike than expected?
3
Phase 3 NORTHSTAR Trial Launches for Gildeuretinol in Stargardt Disease
4




















